Davis Polk, Zhong Lun, Clifford Chance Act On Zhongji InnoLight’s $7B Hong Kong IPO Optical Communication August 4, 2026 Capital Markets – Equity
Davis Polk, Latham & Watkins Act On Epiworld International’s HK$1.6 Bn IPO Semiconductor April 6, 2026 Capital Markets – Equity
Davis Polk, Walkers, Cooley Act On InSilico Medicine’s Hong Kong IPO Biotech January 9, 2026 Capital Markets – Equity
